SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-072010
Filing Date
2019-12-12
Accepted
2019-12-12 07:57:08
Documents
5
Period of Report
2019-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-24992_18k.htm 8-K 33725
2 EX-10.1 a19-24992_1ex10d1.htm EX-10.1 657810
3 EX-10.2 a19-24992_1ex10d2.htm EX-10.2 108233
4 EX-99.1 a19-24992_1ex99d1.htm EX-99.1 9161
5 GRAPHIC g249921mmi001.jpg GRAPHIC 2178
  Complete submission text file 0001104659-19-072010.txt   813355
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13111 | Film No.: 191281056
SIC: 2834 Pharmaceutical Preparations